BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37015104)

  • 41. The Relationships Among Cash Prices, Negotiated Rates, And Chargemaster Prices For Shoppable Hospital Services.
    Wang Y; Meiselbach MK; Cox JS; Anderson GF; Bai G
    Health Aff (Millwood); 2023 Apr; 42(4):516-525. PubMed ID: 37011313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Large Variation in Listed Chargemaster Price for Total Joint Arthroplasty Among Top Orthopaedic Hospitals in the United States.
    Pollock JR; Doan MK; Moore ML; Haglin JM; Arthur JR; Deckey DG; Patel KA; Bingham JS
    J Am Acad Orthop Surg Glob Res Rev; 2023 Sep; 7(9):. PubMed ID: 37678834
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insurers negotiate lower hospital prices for HIX than for commercial groups.
    Randall S; Duffy EL; Green S; Trish E
    Am J Manag Care; 2022 Sep; 28(9):e347-e350. PubMed ID: 36121367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US.
    Horný M; Shafer PR; Dusetzina SB
    JAMA Netw Open; 2021 Dec; 4(12):e2137390. PubMed ID: 34902037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent trends in medicare utilization and reimbursement for lumbar spine fusion and discectomy procedures.
    Lopez CD; Boddapati V; Lombardi JM; Lee NJ; Saifi C; Dyrszka MD; Sardar ZM; Lenke LG; Lehman RA
    Spine J; 2020 Oct; 20(10):1586-1594. PubMed ID: 32534133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Price transparency implementation: Accessibility of hospital chargemasters and variation in hospital pricing after CMS mandate.
    Lu AJ; Chen EM; Vutam E; Brandt J; Sadda P
    Healthc (Amst); 2020 Sep; 8(3):100443. PubMed ID: 32919582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of Price Transparency via National Cancer Institute-Designated Cancer Centers' Chargemasters for Prostate Cancer Radiation Therapy.
    Agarwal A; Dayal A; Kircher SM; Chen RC; Royce TJ
    JAMA Oncol; 2020 Mar; 6(3):409-412. PubMed ID: 31944219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variations in Payer-Negotiated Prices for Head and Neck Reconstructive Surgery.
    Wu SS; Rathi VK; Byrne PJ; Fritz MA; Shaye DA; Lee LN; Sethi RKV; Lindsay RW; Xiao R
    Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1154-1162. PubMed ID: 37337449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ongoing Challenges With Price Transparency in Hospital Charges for Hand Procedures.
    Rhee BS; Kalliainen LK
    J Hand Surg Am; 2023 Dec; 48(12):1263-1267. PubMed ID: 37676189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. US Hospital Characteristics Associated With Price Transparency Regulation Compliance.
    Ji Y; Kong E
    JAMA Health Forum; 2022 Jun; 3(6):e221702. PubMed ID: 35977242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What Is the Value of Undergoing Surgery for Spinal Metastases at Dedicated Cancer Centers?
    Malik AT; Khan SN; Voskuil RT; Alexander JH; Drain JP; Scharschmidt TJ
    Clin Orthop Relat Res; 2021 Jun; 479(6):1311-1319. PubMed ID: 33543875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Making Meaningful Use of Price Transparency Data: Describing Price Variation of Spine Surgery and Imaging in a Single System.
    Olufawo MO; Evans SS; Stecher PT; Youkilis SL; Dibble CF; Greenberg JK; Ray WZ; Hamilton BH; Leuthardt EC
    Neurosurgery; 2022 Sep; 91(3):e88-e94. PubMed ID: 35876670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Availability of consumer prices from US hospitals for a common surgical procedure.
    Rosenthal JA; Lu X; Cram P
    JAMA Intern Med; 2013 Mar; 173(6):427-32. PubMed ID: 23400757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hospital Charges Are Not Associated With Episode-of-Care Costs or Complications After Total Joint Arthroplasty.
    D'Amore T; Goh GS; Courtney PM; Klein GR
    J Arthroplasty; 2022 Aug; 37(8S):S727-S731. PubMed ID: 35051609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Publicly Disclosed Pricing for Common Upper-Extremity Procedures: An Analysis of Hospital Chargemasters.
    Ozdag Y; Hayes DS; Boualam B; Foster BK; Klena JC; Grandizio LC
    Hand (N Y); 2023 Feb; ():15589447221150522. PubMed ID: 36760038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of Commercial-to-Medicare Relative Prices With Health System Financial Performance.
    Blavin F; Kane N; Berenson R; Blanchfield B; Zuckerman S
    JAMA Health Forum; 2023 Feb; 4(2):e225444. PubMed ID: 36763368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medicare Charges and Payments for Cervical Spine Surgery: Association With Hospital Characteristics.
    Skolasky RL; Riley LH
    Spine (Phila Pa 1976); 2015 Aug; 40(16):E936-42. PubMed ID: 25822546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Negotiated Rates for Surgical Cancer Care in the Era of Price Transparency-Prices Reflect Market Competition.
    Rochlin DH; Rizk NM; Matros E; Wagner TH; Sheckter CC
    Ann Surg; 2024 Mar; 279(3):385-391. PubMed ID: 37678179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association Between Cancer Center Accreditation and Compliance With Price Disclosure of Common Oncologic Surgical Procedures.
    Zhang Y; Cerullo M; Esposito A; Golla V
    J Natl Compr Canc Netw; 2022 Nov; 20(11):1215-1222.e1. PubMed ID: 36351331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent trends in medicare utilization and reimbursement for anterior cervical discectomy and fusion.
    Lopez CD; Boddapati V; Lombardi JM; Sardar ZM; Dyrszka MD; Lehman RA; Riew KD
    Spine J; 2020 Nov; 20(11):1737-1743. PubMed ID: 32562771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.